3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Rhabdomyosarcoma
2
Sarcoma, Myeloid
1
Sarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
PRETEXT I Hepatoblastoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Malignant mesenchymal tumor
1
Leukemia, Biphenotypic, Acute
1
Ganglioneuroblastoma
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
selinexor
2
pembrolizumab
2
pazopanib
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ifosfamide
2
Doxorubicin
2
tazemetostat
1
metarrestin
1
fludarabine phosphate
1
fludarabine
1
Specimen Handling
1
Sirolimus
1
Radiotherapy
1
Radiation
1
Proton Therapy
1
Mesna
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
Dexrazoxane
×
90 days
×
Clear all
No trials found.